• The New Money
  • Posts
  • Electric Air Taxis In The UAE, A Breakthrough Breast Cancer Trial, And Pomp's Big Plans For New ETFs

Electric Air Taxis In The UAE, A Breakthrough Breast Cancer Trial, And Pomp's Big Plans For New ETFs

Uncovering the world’s most exciting early stage companies. Discover what’s next.

The Public Company Looking To Launch Dubai’s First Electric Air Taxi

Joby Aviation (NYSE: JOBY) has officially submitted their Letter of Intent to obtain an official Air Operator Certificate from the UAE General Civil Aviation Authority to begin operating their electric air taxis on regional flights. If granted approval, they will become the first legally certified operator of electric air taxis in the UAE.

New Breast Cancer Trial Has Begun Dosing Patients

Atossa Therapeutics (NASDAQ: ATOS) has officially dosed their first patient in their clinical trial partnership with Quantum Leap Healthcare Collaborative which is aiming to validate Atossa’s proprietary (Z)-Endoxifen drug in combination with Abemaciclib for breast cancer treatment. The proprietary drug could represent a potential breakthrough treatment that is both effective and safe for patients that are unlikely to experience any benefit from traditional chemotherapy.

Anthony Pompliano Has Big Plans For New ETFs In The USA

Anthony Pompliano has launched a partnership with DeFi Technologies (CBOE: DEFI) to begin listing new ETFs in the United States through his investment company Professional Capital Management. The new partnership will leverage the infrastructure that DeFi Technologies has built from successfully launching Exchange Traded Products on the Nordic Growth Market which are focused exclusively on digital assets and popular decentralized finance projects.

The Sprint

New here? Join our community of 25,000+ individuals interested in uncovering the world’s most exciting early stage companies.

Disclaimer: The New Money provides background information on early stage companies from publicly available sources. The New Money provides no advice on dealing in securities, is not a financial adviser and does not pretend to be so. This message is meant for information and educational purposes only. The information contained in this email is not to be considered factual or complete. Anybody interested in obtaining financial and other information on companies mentioned is advised to get it direct from the companies, or from their own investment adviser. The New Money does not intend for this information to be used to inform an investment decision. The New Money has been compensated by some of the companies mentioned in this email for awareness campaigns, which affects our ability to be unbiased. The Principals of The New Money may buy or sell shares of the mentioned companies without further notice. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. The New Money and its principals and agents are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Always do your own research and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy or Sell securities. No representation is being made that any stock trade will or is likely to achieve profits. Comparisons made to other featured companies or past performance is not indicative of future results.